title: Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?
authors.forename: Carsten
authors.initials: C
authors.lastname: Bokemeyer
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage* / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005838:Genotype; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D011379:Prognosis; D011658:Pulmonary Fibrosis / Q000139:chemically induced; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000235:genetics*
chemical_list: D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin